IQVIA Holdings Inc.
NYSE:IQVMedical - Diagnostics & Research
-$3.13 today
- Market cap
- $42.49B
- Beta
- 1.22
- P/E (TTM)
- 20.4
- EPS (TTM)
- $8.22
Volume 1.40M
Average 1.62M
IQV Net Income
Bottom-line profit, the starting point for calculating cash from operations.
IQVIA Holdings Inc.NYSE: IQV
Net Income · Q2 FY2026 · quarter ended Jun 2026
Net income dips below year-ago levels
Q2 FY2026 net income of $258M fell 3.0% year over year, behind the +11.5% change in trailing-twelve-month net income. Sequentially, it fell 6.2% from the prior quarter. Over 3 fiscal years it compounded at +7.6% a year.
Context
- Net income amounted to 8.3% of revenue in FY2025, down 0.6 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 14 analysts of $2.25B (+65.4%) for the fiscal year ending Dec 2026, a step up from the -0.9% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $258M-6.2% QoQ
- Last fiscal yearDec 2025
- $1.36B-0.9% YoY
- LTMJun 2026
- $1.38B+11.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -3.0% | +64.0% | +67.0 pp |
| 1 year | -0.9% | +65.4% | +66.2 pp |
| 3-year CAGR | +7.6% | +24.9% | +17.3 pp |
| 5-year CAGR | +20.3% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 1.36B USD
- Year-over-year change
- -0.9%
- 4-year CAGR
- +8.9%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.36B | -0.9% |
| FY2024 | 2024-12-31 | 1.37B | +1.1% |
| FY2023 | 2023-12-31 | 1.36B | +24.5% |
| FY2022 | 2022-12-31 | 1.09B | +12.9% |
| FY2021 | 2021-12-31 | 966M | — |
Net Income vs competitors
How IQV compares with its peers on the latest reported figures
- IQV's LTM Jun 2026 net income of $1.38B is the largest of the 9 companies compared; the peer median is $34.63M.
- Its year-over-year change of +11.5% is the 6th highest of 9, against a peer median of +22.4%.
- Net income amounts to 8.1% of revenue for IQV, versus a peer median of 4.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.38B | +11.5% | +7.6% | 8.1% | |
| LTM Jul 2026 | $1.01B | +25.3% | +23.1% | 29.3% | |
| LTM Sep 2026 | $517.83M | +19.6% | +22.5% | 18.2% | |
| LTM Mar 2026 | $265.26M | +265.1% | +9.0% | 87.7% | |
| LTM Jun 2026 | $248.21M | -68.7% | -23.2% | 3.0% | |
| LTM Jun 2026 | $236.56M | +264.6% | — | 5.9% | |
FTREFortrea Holdings Inc. | LTM Jun 2026 | $85.2M | -91.8% | — | 3.2% |
| LTM Sep 2026 | $54.17M | -73.4% | -5.4% | 3.6% | |
| LTM Mar 2026 | $15.1M | +475.3% | — | 3.6% | |
| Peer median (excluding IQV) | $34.63M | +22.4% | +9.0% | 4.8% | |
Competitors are the stored peer set for IQV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 966M | 1.09B | 1.36B | 1.37B | 1.36B |
| Depreciation & Amortization | 1.26B | 1.13B | 1.13B | 1.11B | 1.14B |
| Deferred Income Tax | (138M) | (115M) | (269M) | (129M) | (180M) |
| Stock-Based Compensation | 170M | 194M | 217M | 206M | 247M |
| Change in Working Capital | 680M | (84M) | (280M) | 158M | 125M |
| Accounts Receivables | (138M) | (421M) | (388M) | 182M | 60M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 244M | 427M | 267M | 115M | (96M) |
| Other Working Capital | 574M | (90M) | (159M) | (139M) | 161M |
| Other Non-Cash Items | 0 | 44M | (2M) | (6M) | (43M) |
| Operating Cash Flow | 2.94B | 2.26B | 2.15B | 2.72B | 2.65B |
| Capital Expenditures | (640M) | (674M) | (649M) | (602M) | (603M) |
| Acquisitions (Net) | (1.46B) | (1.34B) | (876M) | (710M) | (1.76B) |
| Purchases of Investments | (15M) | (5M) | (83M) | (134M) | (20M) |
| Sales of Investments | 5M | 0 | 0 | 0 | 2M |
| Other Investing Activities | 5M | 8M | 5M | 2M | 74M |
| Investing Cash Flow | (2.1B) | (2.01B) | (1.6B) | (1.44B) | (2.31B) |
| Debt Repayment | 70M | 941M | 802M | 553M | 1.21B |
| Common Stock Issued | 0 | 0 | 0 | 0 | (67M) |
| Common Stock Repurchased | (406M) | (1.17B) | (992M) | (1.35B) | (1.24B) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (899M) | (102M) | (192M) | (81M) | (44M) |
| Financing Cash Flow | (1.24B) | (329M) | (382M) | (878M) | (150M) |
| Effect of Forex Changes | (52M) | (75M) | (4M) | (68M) | 79M |
| Net Change in Cash | (448M) | (150M) | 160M | 326M | 278M |
| Free Cash Flow | 2.3B | 1.59B | 1.5B | 2.11B | 2.05B |
IQVIA Holdings Inc.
NYSE:IQV
Intrinsic Alpha fair value
Locked
Current Price
$257.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.